Morepen Labs Files FY26 Annual Report, Announces 41st AGM

Morepen Laboratories Ltd has filed its Annual Report for the financial year 2025-26, along with the notice for its 41st Annual General Meeting (AGM). The AGM is scheduled for September 26, 2026, and will be conducted via Video Conferencing/Other Audio Video Means. The report highlights the company's strategic focus on strengthening its people, technologies, processes, and purpose, serving millions through APIs, formulations, OTC healthcare products, and home diagnostics. It also mentions investments in manufacturing capacity, innovation-led chemistry, digital health, and global partnerships. The company secured a significant multi-year CDMO mandate valued at approximately ₹825 Crore (USD 91 million) from a leading global pharmaceutical company.